Search

Vaxcyte Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

66.56 0.08

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

64

Max

67.11

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-284M

-605M

Pelnas, tenkantis vienai akcijai

-1.97

Darbuotojai

507

EBITDA

22M

-292M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+78.22% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-02

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.3B

11B

Ankstesnė atidarymo kaina

66.48

Ankstesnė uždarymo kaina

66.56

Naujienos nuotaikos

By Acuity

100%

0%

313 / 340 reitingas Healthcare

Vaxcyte Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-07 22:11; UTC

Vaxcyte Inc is declining in after-market trading, continuing a trend of three consecutive lower daily closes, though it remains above its 20-day moving average.

2026-10-06 20:02; UTC

News
Event
Social Media

Vaxcyte Inc shares fell sharply as the company announced public offerings totaling $1 billion, raising concerns over potential equity dilution amid pricing uncertainty.

2026-10-05 23:01; UTC

News
Social Media
Event

Vaxcyte Inc announced $1 billion in dual public offerings for common stock and convertible notes, leading to a significant decline in after-market trading.

2026-10-02 20:12; UTC

Vaxcyte Inc's shares advanced in after-market trading following Friday's close, holding steady near the lower end of its one-month range.

2026-10-01 20:13; UTC

Vaxcyte Inc's shares advanced in after-market hours, gaining ground since the prior close, despite remaining significantly below its 20-day moving average.

2026-09-29 19:55; UTC

Vaxcyte Inc shares fell sharply, trading significantly below their 20-day moving average and near the lower end of their one-month range.

2026-09-28 20:07; UTC

News

Vaxcyte Inc shares are trading higher as B of A Securities maintains its Buy rating while lowering the price target to $130.

2026-09-24 19:46; UTC

Vaxcyte Inc is trading modestly higher, having fluctuated throughout the day but remains below its 20-day moving average and near the lower end of its one-month range.

2026-09-23 20:02; UTC

Correlated Moves

Vaxcyte Inc shares fell sharply, influenced by a significant drop in the Direxion Daily S&P Biotech Bull 3X ETF and earlier session highs.

2026-09-18 20:02; UTC

Vaxcyte Inc shares fell sharply, reaching their lowest cumulative return since Thursday and remaining well below the 20-day moving average.

2026-09-17 20:07; UTC

Correlated Moves

Vaxcyte Inc is gaining, likely influenced by the SPDR S&P Biotech ETF's rise following positive Phase 3 results from Moderna's cancer vaccine.

2026-09-16 19:16; UTC

Macro Event

Vaxcyte Inc shares fell amid broader market volatility following the Federal Reserve's 25 basis point interest rate hike, remaining near the lower end of their one-month range.

2026-09-14 20:08; UTC

Vaxcyte Inc shares are higher today, reflecting broader market trends. Earlier in the session, the stock pulled back but remains above Friday's close.

2026-09-09 19:46; UTC

Vaxcyte Inc shares are lower today, fluctuating from an early gain to a mid-afternoon decline. The stock is near its one-month trading range low.

2026-09-08 23:31; UTC

Vaxcyte Inc shares declined in after-hours trading, now below their 20-day moving average and near the lower end of their one-month trading range.

2026-09-04 20:08; UTC

News

Vaxcyte Inc. appointed new executives and accelerated its timeline for trial data, with shares trading lower during Friday's session.

2026-09-03 20:14; UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2026-09-02 20:08; UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

2026-09-01 20:09; UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

2026-08-31 19:16; UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

2026-08-28 20:07; UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

2026-08-25 20:07; UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

2026-08-24 19:46; UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

2026-08-21 21:01; UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

2026-08-20 23:46; UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

2026-08-19 20:02; UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

2026-08-14 20:06; UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

2026-08-12 19:46; UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

2026-08-11 23:11; UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

2026-08-10 19:56; UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

Akcijų palyginimas

Kainos pokytis

Vaxcyte Inc Prognozė

Kainos tikslas

By TipRanks

78.22% į viršų

12 mėnesių prognozė

Vidutinis 118.875 USD  78.22%

Aukščiausias 163 USD

Žemiausias 75 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vaxcyte Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

7

Pirkti

1

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.